The Key to Prostate Cancer (eBook)

Preface A Path to Self-EducationForeword Th e Paradox of ChoiceIntroduction Synopsis of TreatmentsI. Staging and Prognosis 1. Quiz to Assign a Stage of Blue - Peter Scholz2. Th e PSA Blood Test - Stanley Brosman, MD3. Interpreting the Pathology Report - Jonathan Epstein, MD4. Multiparametric MRI and Targeted Biopsy - Daniel Margolis, MD5. Color Doppler Ultrasound and Targeted Biopsy - Duke Bahn, MD6. Body Scans and Other Prognostic Factors - Fabio Almeida, MD7. Picking the Right Doctor - Ralph BlumII. The Sky Stage of Blue8. Overview of Sky - Mark Scholz, MD9. The Science Behind Active Surveillance - Laurence Klotz, MD10. Focal Cryosurgery - Duke Bahn, MD11. Introduction to Treatment-Related Side Effects - Mark Scholz, MD12. Sexual Dysfunction - Kelly Chiles, MD and John Mulhall, MD13. Surgical Side Effects Affecting Urination - Gary Leach, MD14. Side Effects from Radiation Therapy - Henry Yampolsky, MD15. Summary of Sky - Mark Scholz, MDIII. The Teal Stage of Blue16. Overview of Teal - Mark Scholz, MD17. Permanent Radioactive Seed Implants - Peter Grimm, DO and John Blasko, MD18. High-Dose-Rate Seeds - D. Jeffrey Demanes, MD19. IMRT for Teal - Zachary Zumsteg, MD and Howard Sandler, MD20. Combination Therapy for Intermediate-Risk - Sean McBride, MD and Michael Zelefsky, MD21. Proton Beam Therapy - Carl Rossi, MD22. Stereotactic Body Radiation Therapy (SBRT) - Michael Steinberg, MD23. TIP Alone as Primary Therapy for Teal - Mark Scholz, MD24. Robotic Radical Prostatectomy - Timothy Wilson, MD25. Comparing Treatments for Teal - Mark Scholz, MDIV. The Azure Stage of Blue26. Overview of Azure - Mark Scholz, MD27. Testosterone Inactivating Pharmaceuticals (TIP) - Mark Scholz, MD28. The Azure Stage of Prostate Cancer - Mark Scholz, MD29. Unorthodox Therapies for High-Azure - Mark Scholz, MD30. Reducing the Side Effects of TIP - Mark Scholz, MDV. The Indigo Stage of Blue31. Overview of Indigo - Mark Scholz, MD32. Introduction to Radiation for Indigo - Christopher Rose, MD33. Indigo—Cancer Relapse or Pelvic Node Disease - Mark Scholz, MD34. Unorthodox Therapies for Indigo - Mark Scholz, MD35. Minimizing the Side Effects of Chemotherapy - Richard Lam, MD36. Indigo—Situations in which PSA is Misleading - Mark Scholz, MDVI. The Royal Stage of Blue37. Overview of Royal - Mark Scholz, MD38. Early Hormonal Resistance: Low-Royal - Mark Scholz, MD39. Oligometastatic Prostate Cancer: Basic-Royal - Jeffrey Turner, MD40. Treatments for High-Royal - Richard Lam, MD41. Unorthodox Therapies for Royal - Mark Scholz, MD42. Immunotherapy for Prostate Cancer - Charles Drake, MD43. Genetically Targeted Therapy - Mark Scholz, MD44. Cancer Research: Striving to Live Longer and Better - Luke Nordquist, MD45. Pain Management - Mark Scholz, MDVII. Lifestyle and General Health Issues46. Health Issues for Men with Prostate Cancer - Jeffrey Turner, MD47. Whole Nutrition for Prostate Health and Recovery -Verne Varona48. Fitness and Longevity - Mark Scholz, MD49. Supplements for Prostate Cancer - Mark Moyad, MD50. The Key: Knowing Your Stage of Blue - Mark Scholz, MD